Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Divaplay 250 Tablet ER

Prescription Icon
Prescription Required

Marketer

Care Formulation Labs Pvt Ltd

Salt Composition

Divalproex (250mg)

Overview Divaplay 250 Tablet ER

Epileptic seizures and migraine prophylaxis are key indications for Divaplay 250 ER tablets. This medication can also be employed in managing bipolar disorder, sometimes in conjunction with other therapies. Dosage and frequency are determined individually by your physician to optimize symptom control. Administer the medication consistently, at the same time daily, with or without food, for maximum efficacy. Therapeutic effects typically manifest within a couple of weeks. Consistent adherence is crucial; discontinuation or missed doses may exacerbate the underlying condition or trigger seizures; abrupt cessation is contraindicated. Commonly reported side effects include dizziness, nausea, vomiting, headache, blurred vision, fatigue, ataxia, bruising, and hypothermia—most are mild and transient. However, report persistent or bothersome effects, particularly skin rashes, to your physician promptly. Long-term use may reduce bone density, increasing fracture risk, and, rarely, may precipitate suicidal ideation or behavior; report any mood changes immediately. Prior to initiating Divaplay 250 ER, disclose any pre-existing cardiac, hepatic, renal, or urinary issues, as well as a history of depression or suicidal thoughts. Inform your doctor of all concurrent medications to avoid potential drug interactions. Pregnancy necessitates consultation with your doctor before starting or stopping treatment. Alcohol consumption should be minimized due to the potential for increased side effects and seizure risk. Regular blood tests may be required to monitor therapeutic drug levels both before and during treatment.

Uses of Divaplay 250 Tablet ER

Managing epileptic seizures and bipolar disorder, plus migraine prevention.

Major Benefits of Divaplay 250 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Divaplay 250 ER tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Divaplay 250 Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Divaplay 250 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Divaplay 250 Extended-Release Tablets can be administered with or without food, although consistent timing is recommended.

How Divaplay 250 Tablet ER works:

Extended-release Divaplay 250mg tablets are used to treat epilepsy. Their mechanism involves reducing hyperactivity within the brain's neuronal network, thus managing seizures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Divaplay 250 Extended-Release tablets and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Divaplay 250 mg tablets are contraindicated in pregnancy due to confirmed fetal risk. Nevertheless, in exceptional life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the hazards. Physician consultation is recommended.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Divaplay 250 mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no apparent risk to the infant.

DrivingDrivingUNSAFE

Extended-release Divaplay 250mg tablets may impair driving ability due to potential adverse reactions.

KidneyKidneySAFE IF PRESCRIBED

Divaplay 250 Extended-Release tablets pose no safety concerns for patients with renal impairment; no dosage modification is necessary.

LiverLiverUNSAFE

Extended-release Divaplay 250mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is advised.

What if you forget to take Divaplay 250 Tablet ER :

Should you forget a Divaplay 250 Tablet ER dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Divaplay 250 Tablet ER

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Actions Antiepileptic drugs targeting sodium channels

FAQs on Divaplay 250 Tablet ER

Always consult your doctor before discontinuing Divaplay 250 Tablet ER. Withdrawal should be gradual, under medical supervision, to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors.
Divaplay 250 Tablet ER may be used to stabilize mood in individuals experiencing rapid mood swings. Its mechanism involves reducing excessive brain activity associated with these mood changes.
Divaplay 250 Tablet ER can cause weight gain, potentially due to increased appetite. Maintain a healthy diet and exercise to mitigate this. Consult your doctor if weight gain is a concern.
Drowsiness is a possible side effect of Divaplay 250 Tablet ER. Refrain from driving or activities requiring alertness until you understand its effects on you.
Hair loss is a possible, though typically temporary and dose-dependent, side effect of Divaplay 250 Tablet ER. Consult your doctor if you experience persistent or concerning hair loss.
Divaplay 250 Tablet ER can cause liver damage, particularly within the first six months of treatment. Symptoms may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes). Liver function tests are recommended before starting and regularly during the initial six months, especially for at-risk individuals or those with a history of liver disease.
Refrain from drinking alcohol during your Divaplay 250 Tablet ER treatment. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Divaplay 250 Tablet ER treatment, your doctor may order blood tests. These may include a complete blood count (with platelet count), bleeding time, and coagulation tests to help prevent unexpected bleeding or bruising. Liver function tests are also recommended before, and regularly monitored during the first six months of treatment, particularly for high-risk individuals or those with pre-existing liver conditions.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may test your serum amylase levels; a positive result necessitates immediate medication cessation.
Divaplay 250 Tablet ER overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Muscle weakness, seizures, loss of consciousness, altered behavior, and respiratory problems (rapid breathing, shortness of breath, chest pain) are also possible. Seek immediate medical help if an overdose occurs.
Divaplay 250 Tablet ER
67
MRP 82
18% off